What is Combinatorial
Chemistry ?
Combinatorial chemistry is a new technique developed in pharmaceutical
industry, which involves synthesis of compounds in mass, which are
screened as a whole mixture for particular biological activity.
It has reduced the time and cost to produce effective and marketable new
drugs.
Combinatorial Libraries
Collection of structurally related compounds (peptides, oligonucleotides,
oligosaccharides, organic molecules) obtainable by chemical or biological
means simultaneously as a mixture and screened for activity as a mixture of
compounds.
Size : Depends on the number of building blocks used per reaction and the
number of steps where a new building block is introduced.
Target
compounds
for synthesis
Determine
synthetic
routes
Determine
available
reagents
Identify
active
compounds
Screen and
collect
bioassay data
Build library
Select/store
building
blocks
Parallel Synthesis
Each synthetic reaction is
started in a different reaction
vessel and all the necessary
operations are executed in
parallel.
Solid support as well as solution
chemistry is possible.
Parallel Synthesis
Advantages :
Each compound is substantially pure in its location.
Defined location provides the structure of a certain compounds.
Easier biological evaluation
Disadvantages :
Applicable only for medium libraries.
Disadvantages :
More amount of resin beads required.
Only little amounts of synthetic compounds available.
Screening
Identification of biologically active compound among all the
compounds synthesized.
Virtual Screening : Using computers to predict whether a
compound will show the desired activity based on the 2-D and
3-D structures.
High Throughput Screening (HTS)
done
by
Combinatorial Chemistry:
Synthetic methods
Shweta Rai
School of Chemical Sciences
NISER
1302343
Outline
Methods in combinatorial libraries :
Solid phase synthesis
Parallel synthesis
Mix & split technique
Tea bag synthesis
Multi-pin synthesis
Light-directed synthesis on silica wafers (based on semiconductor
photolithography
Solution phase synthesis
Encoding and Decoding of combinatorial libraries
The linker is the molecule that sits between the compound and the support.
The linker moves the point of the attachment of the substrate away from the surface of the bead.
Different linkers are used depending on whether the functional group is present on the substrate, or the
functional group is desired on the final product once it is released.
Types of linkers:
Wang Resin : Linker suitable for release of carboxylic acids.
Merrifield Resin : Linker suitable for peptide products.
Rink Resin : Linker suitable for attachment & release of carboxamide.
Protecting Group
Protecting groups are important for the blocking & regenerating
certain functional groups in a reaction sequence.
Some examples of protecting groups are :
FMOC ( Fluoro methoxy carbonyl)
TBOC ( Tertiary butyloxy carbonyl)
Multi-Pin Synthesis
The reaction vessels consists of brush like arrays of pins, at the end of its
consists of bead(lollypop) with suitable linker. Here the synthesis takes place.
It is inserted in to the plates where the reagents & the solvents kept
Encoding
Encoding should provide a fast and simple way to identify the structure of all
library members
Classification :
Positional Encoding: In this method the re-synthesis and rescreening is
carried out to know the identity of the active compound.
Chemical encoding: Every reaction used in the library synthesis is recorded
on the solid support by the chemical attachment of a tag.
Electronic encoding: Radio frequency memory chip attached to the solid
support records and emits coded information.
Decoding
Every bead has tags that provide information, once cleaved, about
the chemical history of that bead
Combinatorial Chemistry:
Applications in drug discovery
Because of the long time it takes to develop pharmaceutical drugs there are few examples of
marketed drugs discovered by combinatorial methods.
Whether combinatorial approaches can also be adapted to deal with all the other requirements of
a successful pharmaceutical (lack of toxicity, bioavailability etc.) is open to question but there are
already examples of potential structures obtained from it.
Lets be optimistic !
Peptoids
Poly-N-substituted glycines, are a class of peptide mimetics whose side chains are appended to the
nitrogen atom of the peptide backbone, rather than to the -carbons.
Conformationally unstable, due to the flexibility of the main-chain methylene groups and the
absence of stabilizing hydrogen bond interactions along the backbone.
With appropriate side chains it is possible to form specific steric or electronic interactions that
favour the formation of stable secondary structures
Why peptoids ?
Completely resistant to proteolysis.
Since secondary structure in peptoids does not involve hydrogen bonding, it is not
typically denatured by solvent, temperature, or chemical denaturants such as urea.
Many useful polypeptides sorted from polypeptide libraries have low bioavailability and
unfavourable pharmacokinetic properties.
Therefore focus has shifted to synthetic peptide-mimetics like peptoides.
Synthesis of peptoids
N-substituted glycine units as monomers. (Similar to natural -amino acid side chain.)
Polymerization reaction
Full monomer oligomer synthesis
Sub monomer oligomer synthesis
by combining :
2-aminobenzophenones
Amino acids, and
Alkylating agents.
Points of
diversities
Histamine H3 receptors
Expressed in the CNS and to a lesser extent the PNS, acts as autoreceptors in presynaptic histaminergic neurons, and also controls histamine turnover by feedback inhibition of
histamine synthesis and release.
Is a G-protein coupled receptor. The H3 receptor is coupled to the Gi G-protein, so it leads to
inhibition of the formation of cAMP and hence consequently reduces the release of neurotransmitters down the pathway.
NOTE :
An auto-receptor is a type of receptor located in the membranes of presynaptic nerve cells. It serves
as part of a negative feedback loop in signal transduction. It is only sensitive to
the neurotransmitters or hormones released by the neuron on which the auto-receptor sits.
Gi alpha subunit is a heterotrimeric G protein subunit that inhibits the production of cAMP from ATP.
Ongoing venture. .
Combinatorial lead optimisation of dihydrofolate reductase
inhibitor.
For development of effective antimicrobial agents to treat
infections caused by multi-antibiotic resistant S.aureus and
S.pneumoniae.
A library of 1392 compounds has been already synthesised
and is under evaluation.
Conclusion
Combinatorial approaches have had tremendous impact of the identification of new leads.
Many active compounds have been selected to-date, following combinatorial methodologies, and a
considerable number of those have progressed into clinical trials.
Offers higher productivity at lower expense.
Application in conjunction with computational chemistry and molecular modelling techniques are
coming into picture.
Thank you !